Biotechnology

Jan 31, 2023, 23:34 ET AMGEN POSTS FULL TRANSCRIPT AND AUDIO REPLAY OF FOURTH QUARTER AND FULL YEAR 2022 EARNINGS WEBCAST

Amgen (NASDAQ:AMGN) posted the full transcript and audio replay of the company's 2022 fourth quarter and full year financial results webcast from...

Jan 31, 2023, 17:40 ET Global Large Molecule Drug Substance CDMO Market Report 2022: Sector to Reach $19.2 Billion by 2028 at a CAGR of 8.7%

The "Global Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), ...

Jan 31, 2023, 16:43 ET Myeloid Therapeutics to Present at the Guggenheim Healthcare Talks 2023 Oncology Day

Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, today announced that management will present at the Guggenheim...

Jan 31, 2023, 16:25 ET FDA Roundup: January 31, 2023

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, Brian King, director of the...

Jan 31, 2023, 16:05 ET Poseida Therapeutics Announces Board Change

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...

Jan 31, 2023, 13:56 ET SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, ...

Jan 31, 2023, 12:46 ET FibroBiologics Launches Public Funding Campaign with StartEngine.com

FibroBiologics, a clinical-stage company focused on the development of fibroblast cell-based therapeutics for chronic diseases, today launched an...

Jan 31, 2023, 11:40 ET At 7.5% CAGR, Global Peptide Synthesis Market Size & Share to Surpass US$ 845.68 million By 2028 | Peptide Synthesis Industry Trends, Share, Growth, Value, Analysis & Forecast Report By Facts and Factors

As per Facts and Factors study, The global Peptide Synthesis market size was estimated to be worth roughly USD 509.74 million in 2021 and is...

Jan 31, 2023, 11:29 ET Stemline Therapeutics, ein Unternehmen der Menarini Group, erhält FDA-Zulassung für ORSERDU™ (Elacestrant) als erste und einzige Behandlung speziell für Patienten mit fortgeschrittenem oder metastasiertem ER+-/HER2-Brustkrebs mit ESR1-Mutationen

Jan 31, 2023, 11:25 ET FDA Proposes Redesign of Human Foods Program to Enhance Coordinated Prevention and Response Activities

As the oldest comprehensive consumer protection agency in the country, for more than a century the U.S. Food and Drug Administration has been...

Jan 31, 2023, 11:00 ET Carisma Therapeutics Appoints Leading Solid Tumor Immunotherapy Expert Padmanee Sharma, MD, PhD to Scientific Advisory Board

Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced the ...

Jan 31, 2023, 11:00 ET Antinuclear Antibody Test Market is expected to generate a revenue of USD 4.71 Billion by 2030, Globally, at 12.05% CAGR: Verified Market Research®

Verified Market Research® recently published a report, "Antinuclear Antibody Test Market" By Product (Reagents And Assay Kits, Systems), By Technique ...

Jan 31, 2023, 10:14 ET Applied BioMath, LLC Successfully Completes SOC 2 Certification

Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help...

Jan 31, 2023, 10:10 ET Global Next Generation Computing Market Report 2023: Bio Computing for Molecular Medicine and Gene Therapy Will Reach $19.1 and $12.1 Billion Respectively by 2028

The "Next Generation Computing Market: Bio-Computing, Brain-Computer Interfaces, High Performance Computing, Nanocomputing, Neuromorphic Computing,...

Jan 31, 2023, 09:07 ET RTK GROUP JOINS THE MASSACHUSETTS BIOTECHNOLOGY COUNCIL

RTK Group, LLC, ("RTK Group"), an early-stage advisory and investment fund supporting emerging technologies in the biotech and pharmaceutical sector, ...

Jan 31, 2023, 09:00 ET Kytopen and Mirus Bio Announce Partnership to Unlock New and Scalable Genome Engineering Capabilities for the Next-Generation of Living Medicines

Kytopen, a biotechnology company leading advancements in high-throughput cellular and genome engineering platforms, today announced a partnership...

Jan 31, 2023, 09:00 ET Prescryptive Health anuncia nuevas capacidades de idiomas para aumentar la accesibilidad del paciente

Jan 31, 2023, 09:00 ET Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") today provided an update on the $2 million share repurchase program (the "Share...

Jan 31, 2023, 09:00 ET Prescryptive Health Announces New Language Capabilities to Increase Patient Accessibility

Prescryptive Health, a healthcare technology company on a mission to rewrite the script for the U.S. pharmaceutical market, today announced new...

Jan 31, 2023, 08:50 ET CARsgen Announces Collaboration Agreement to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative therapies for the treatment of hematologic malignancies...